Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

ELK1

ELK1, member of ETS oncogene family


Gene ELK1 gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Female

20.0

Humans

510.0

Hela Cells

70.0

JNK Mitogen-Activated Protein Kinases

40.0

Mitogen-Activated Protein Kinases/metabolism

60.0

Research Support, Non-U.S. Gov't

350.0

Transfection

90.0

p38 Mitogen-Activated Protein Kinases

40.0

*Chromosome Mapping

40.0

Pseudogenes

21.0

Sequence Analysis, DNA

40.0

*X Chromosome

40.0

Proto-Oncogene Proteins/drug effects/metabolism

26.0

Animals

220.0

Cell Division/drug effects

40.0

*DNA-Binding Proteins

160.0

Enzyme Activation/drug effects

50.0

Mice

130.0

Research Support, U.S. Gov't, P.H.S.

210.0

Signal Transduction/*drug effects

30.0

*Transcription Factors

181.0

3T3 Cells

40.0

Amino Acid Sequence

70.0

Enzyme Activation

50.0

Kinetics

40.0

*MAP Kinase Signaling System

21.0

Mitogen-Activated Protein Kinase 1/metabolism

30.0

Mitogen-Activated Protein Kinase 3

50.0

Mitogen-Activated Protein Kinases/*metabolism

50.0

Molecular Sequence Data

160.0

Protein Binding

20.0

Proto-Oncogene Proteins/metabolism

60.0

Rats

60.0

Signal Transduction

40.0

Transcription, Genetic

50.0

Cells, Cultured

60.0

Gene Expression

20.0

Hamsters

20.0

Mitogen-Activated Protein Kinase Kinases/metabolism

31.0

*Proto-Oncogene Proteins

80.0

Proto-Oncogene Proteins c-raf/metabolism

33.0

ras Proteins/metabolism

21.0

Binding Sites

30.0

Cell Line

90.0

Cyclic AMP-Dependent Protein Kinases/metabolism

21.0

DNA/metabolism

50.0

Epidermal Growth Factor/pharmacology

20.0

MAP Kinase Kinase 1

42.0

Promoter Regions (Genetics)

20.0

*Signal Transduction

50.0

Transcription Factors/*genetics

60.0

Mutation

30.0

Base Sequence

120.0

Cloning, Molecular

60.0

Comparative Study

30.0

Gene Expression Regulation/*immunology

21.0

Mutagenesis, Site-Directed

30.0

Reverse Transcriptase Polymerase Chain Reaction

60.0

Sequence Homology, Nucleic Acid

20.0

Trans-Activation (Genetics)/*immunology

210.0

COS Cells

20.0

Phosphorylation/drug effects

40.0

Viral Core Proteins/*pharmacology

250.0

Protein-Serine-Threonine Kinases/metabolism

20.0

Tumor Cells, Cultured

90.0

Cell Line, Transformed

20.0

Mitogen-Activated Protein Kinases/genetics/*metabolism

24.0

Receptor, Bradykinin B2

29.0

Trans-Activation (Genetics)

40.0

Sequence Homology, Amino Acid

40.0

Alleles

20.0

Binding Sites/genetics

20.0

Blotting, Southern

20.0

DNA-Binding Proteins/metabolism

50.0

Genomic Library

20.0

MAP Kinase Signaling System/*drug effects

25.0

Potassium Channels/metabolism

25.0

*Protein-Serine-Threonine Kinases

20.0

Protein-Tyrosine Kinase/metabolism

20.0

DNA Primers

20.0

Enzyme Inhibitors/pharmacology

40.0

*Mitogen-Activated Protein Kinases

20.0

Hybrid Cells

20.0

Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism

20.0

Phosphorylation

60.0

Exons

20.0

Introns

20.0

Regulatory Sequences, Nucleic Acid

20.0

Sequence Alignment

20.0

Sequence Deletion

40.0

Transcription Factors/metabolism

50.0

Cell Cycle

20.0

Growth Substances/pharmacology

21.0

*Gene Expression Regulation

20.0

Serum Response Factor

21.0

Adult

20.0

RNA, Messenger/analysis

20.0

Genome, Human

20.0

Chromosome Mapping

30.0

Proto-Oncogene Proteins/*genetics

40.0

*Chromosomes, Human, Pair 1

20.0

DNA-Binding Proteins/*genetics

40.0

*Oncogene Proteins

23.0

Genes, Regulator/genetics

24.0

Mitogens/pharmacology

20.0

Promoter Regions (Genetics)/genetics

30.0

*Oncogenes

20.0

In Situ Hybridization, Fluorescence

20.0

*Multigene Family

20.0

Restriction Mapping

20.0

Retroviridae Proteins, Oncogenic/*genetics

29.0

Tyrosine/metabolism

20.0

Serum Response Factor/metabolism

222.0

Receptor, Epidermal Growth Factor/metabolism

20.0

Male

20.0

*Genes, fos

23.0